These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28269612)

  • 1. Identifying disease network perturbations through regression on gene expression and pathway topology analysis.
    Dimitrakopoulos GN; Balomenos P; Vrahatis AG; Sgarbas K; Bezerianos A
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5969-5972. PubMed ID: 28269612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradient descent optimization in gene regulatory pathways.
    Das M; Mukhopadhyay S; De RK
    PLoS One; 2010 Sep; 5(9):e12475. PubMed ID: 20838430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathway crosstalk analysis based on protein-protein network analysis in ovarian cancer.
    Pan XH
    Asian Pac J Cancer Prev; 2012; 13(8):3905-9. PubMed ID: 23098491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversified Control Paths: A Significant Way Disease Genes Perturb the Human Regulatory Network.
    Wang B; Gao L; Zhang Q; Li A; Deng Y; Guo X
    PLoS One; 2015; 10(8):e0135491. PubMed ID: 26284649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a computable cell proliferation network focused on non-diseased lung cells.
    Westra JW; Schlage WK; Frushour BP; Gebel S; Catlett NL; Han W; Eddy SF; Hengstermann A; Matthews AL; Mathis C; Lichtner RB; Poussin C; Talikka M; Veljkovic E; Van Hooser AA; Wong B; Maria MJ; Peitsch MC; Deehan R; Hoeng J
    BMC Syst Biol; 2011 Jul; 5():105. PubMed ID: 21722388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodology of predicting novel key regulators in ovarian cancer network: a network theoretical approach.
    Malik MZ; Chirom K; Ali S; Ishrat R; Somvanshi P; Singh RKB
    BMC Cancer; 2019 Nov; 19(1):1129. PubMed ID: 31752757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Intermediary Genes between Pathways Using Sparse Regression.
    Liang KC; Patil A; Nakai K
    PLoS One; 2015; 10(9):e0137222. PubMed ID: 26348038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease.
    Zhang Y; Liu D; Wang L; Wang S; Yu X; Dai E; Liu X; Luo S; Jiang W
    J Mol Med (Berl); 2015 Dec; 93(12):1381-90. PubMed ID: 26208504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inference of signaling and gene regulatory networks by steady-state perturbation experiments: structure and accuracy.
    Andrec M; Kholodenko BN; Levy RM; Sontag E
    J Theor Biol; 2005 Feb; 232(3):427-41. PubMed ID: 15572066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridge and brick network motifs: identifying significant building blocks from complex biological systems.
    Huang CY; Cheng CY; Sun CT
    Artif Intell Med; 2007 Oct; 41(2):117-27. PubMed ID: 17825540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-based methods for identifying critical pathways of complex diseases: a survey.
    Zhang Q; Li J; Xue H; Kong L; Wang Y
    Mol Biosyst; 2016 Apr; 12(4):1082-9. PubMed ID: 26888073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
    Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
    Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Path2enet: generation of human pathway-derived networks in an expression specific context.
    Droste C; De Las Rivas J
    BMC Genomics; 2016 Oct; 17(Suppl 8):731. PubMed ID: 27801297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying functional gene regulatory network phenotypes underlying single cell transcriptional variability.
    Park J; Ogunnaike B; Schwaber J; Vadigepalli R
    Prog Biophys Mol Biol; 2015 Jan; 117(1):87-98. PubMed ID: 25433230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-Oriented Approaches to Anticancer Drug Response.
    Lecca P; Re A
    Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
    Rajamani D; Bhasin MK
    Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.